These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37127317)

  • 1. Integrating PROMIS Measures in a Treat-to-Target Approach to Standardize Patient-Centered Treatment of Rheumatoid Arthritis.
    Greene GJ; Beaumont JL; Bacalao EJ; Muftic A; Kaiser K; Eisenstein AR; Mandelin AM; Cella D; Ruderman EM
    J Rheumatol; 2023 Aug; 50(8):1002-1008. PubMed ID: 37127317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardizing and personalizing the treat to target (T2T) approach for rheumatoid arthritis using the Patient-Reported Outcomes Measurement Information System (PROMIS): baseline findings on patient-centered treatment priorities.
    Bacalao EJ; Greene GJ; Beaumont JL; Eisenstein A; Muftic A; Mandelin AM; Cella D; Ruderman EM
    Clin Rheumatol; 2017 Aug; 36(8):1729-1736. PubMed ID: 28653263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responsiveness of Patient-Reported Outcomes Measurement Information System Measures in Rheumatoid Arthritis Patients Starting or Switching a Disease-Modifying Antirheumatic Drug.
    Wohlfahrt A; Bingham CO; Marder W; Phillips K; Bolster MB; Moreland LW; Zhang Z; Neogi T; Lee YC
    Arthritis Care Res (Hoboken); 2019 Apr; 71(4):521-529. PubMed ID: 29885039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A patient-centered knowledge translation tool for treat-to-target strategy in rheumatoid arthritis: Patient and rheumatologist perspectives.
    Benham H; Chiu H; Tesiram J; Mehdi A; Landsberg P; Grosman S; Harrison A; Nash P; Thomas R; Langbecker D; Van Driel M
    Int J Rheum Dis; 2021 Mar; 24(3):355-363. PubMed ID: 33470051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion of Functional Assessment of Chronic Illness Therapy-Fatigue to Patient-Reported Outcomes Measurement Information System Fatigue Scores in Two Phase III Baricitinib Rheumatoid Arthritis Trials.
    Bingham CO; Bartlett SJ; Kannowski C; Sun L; DeLozier AM; Cella D
    Arthritis Care Res (Hoboken); 2021 Apr; 73(4):481-488. PubMed ID: 31961494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Older age at rheumatoid arthritis onset and comorbidities correlate with less Health Assessment Questionnaire-Disability Index and Clinical Disease Activity Index response to etanercept in the RADIUS 2 registry.
    Martin WJ; Shim M; Paulus HE; Chaudhari S; Feng J; Elashoff D; Hahn TJ; Ranganath VK;
    J Clin Rheumatol; 2014 Sep; 20(6):301-5. PubMed ID: 25160011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis.
    Ranganath VK; Maranian P; Elashoff DA; Woodworth T; Khanna D; Hahn T; Sarkisian C; Kremer JM; Furst DE; Paulus HE
    Rheumatology (Oxford); 2013 Oct; 52(10):1809-17. PubMed ID: 23813577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining the acceptable level of physician compliance with a treat-to-target strategy in early rheumatoid arthritis.
    Wabe N; Sorich MJ; Wechalekar MD; Cleland LG; McWilliams L; Lee A; Spargo L; Metcalf R; Hall C; Proudman SM; Wiese MD
    Int J Rheum Dis; 2017 May; 20(5):576-583. PubMed ID: 26692459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining the Minimally Important Difference in the Clinical Disease Activity Index for Improvement and Worsening in Early Rheumatoid Arthritis Patients.
    Curtis JR; Yang S; Chen L; Pope JE; Keystone EC; Haraoui B; Boire G; Thorne JC; Tin D; Hitchon CA; Bingham CO; Bykerk VP
    Arthritis Care Res (Hoboken); 2015 Oct; 67(10):1345-53. PubMed ID: 25988705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM).
    Ramiro S; Landewé RB; van der Heijde D; Sepriano A; FitzGerald O; Ostergaard M; Homik J; Elkayam O; Thorne JC; Larche M; Ferraccioli G; Backhaus M; Boire G; Combe B; Schaeverbeke T; Saraux A; Dougados M; Rossini M; Govoni M; Sinigaglia L; Cantagrel AG; Allaart CF; Barnabe C; Bingham CO; Tak PP; van Schaardenburg D; Hammer HB; Dadashova R; Hutchings E; Paschke J; Maksymowych WP
    Ann Rheum Dis; 2020 Apr; 79(4):453-459. PubMed ID: 32094157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to remission in swollen joints is far faster than patient reported outcomes in rheumatoid arthritis: results from the Ontario Best Practices Research Initiative (OBRI).
    Pope JE; Rampakakis E; Movahedi M; Cesta A; Sampalis JS; Bombardier C;
    Rheumatology (Oxford); 2021 Feb; 60(2):717-727. PubMed ID: 32789456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of treat-to-target strategy in established rheumatoid arthritis: a daily practice prospective cohort study.
    de Andrade NPB; da Silva Chakr RM; Xavier RM; Viecceli D; Correa RHB; de Oliveira Filho CM; Brenol CV
    Rheumatol Int; 2017 Jun; 37(6):993-997. PubMed ID: 28293776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PROMIS Fatigue short forms are reliable and valid in adults with rheumatoid arthritis.
    Bingham Iii CO; Gutierrez AK; Butanis A; Bykerk VP; Curtis JR; Leong A; Lyddiatt A; Nowell WB; Orbai AM; Bartlett SJ
    J Patient Rep Outcomes; 2019 Feb; 3(1):14. PubMed ID: 30790155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of rheumatoid arthritis in clinical practice using treat-to-target strategy: Where do we stand in the multi-ethnic Malaysia population?
    Tan BE; Lim AL; Kan SL; Lim CH; Ng YF; Tng SLC; Hassin NS; Chandran L; Hamid NA; Lee YYL
    Rheumatol Int; 2017 Jun; 37(6):905-913. PubMed ID: 28389855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis.
    Tanaka Y; Smolen JS; Jones H; Szumski A; Marshall L; Emery P
    Arthritis Res Ther; 2019 Jul; 21(1):164. PubMed ID: 31277720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to treatment optimization and achievement of patients' goals: perspectives from people living with rheumatoid arthritis enrolled in the ArthritisPower registry.
    Gavigan K; Nowell WB; Serna MS; Stark JL; Yassine M; Curtis JR
    Arthritis Res Ther; 2020 Jan; 22(1):4. PubMed ID: 31910893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year.
    Kay J; Morgacheva O; Messing SP; Kremer JM; Greenberg JD; Reed GW; Gravallese EM; Furst DE
    Arthritis Res Ther; 2014 Feb; 16(1):R40. PubMed ID: 24485007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily practice feasibility and effectiveness of treating long-standing rheumatoid arthritis to target with synthetic disease-modifying antirheumatic drugs: a prospective cohort study.
    Brenol CV; da Chakr RM; Andrade NP; Toni M; Laurindo IM; Brenol JC; Xavier RM
    Clin Rheumatol; 2015 Oct; 34(10):1781-5. PubMed ID: 25771853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doppler ultrasound impacts response to intravenous tocilizumab in rheumatoid arthritis patients.
    Morris NT; Brook J; Ben-Artzi A; Martin W; Kermani TA; Avedikian-Tatosyan L; Karpouzas G; Nagam H; Navarro G; Choi S; Taylor MB; Elashoff D; Kaeley GS; Ranganath VK
    Clin Rheumatol; 2021 Dec; 40(12):5055-5065. PubMed ID: 34269927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients and clinicians define symptom levels and meaningful change for PROMIS pain interference and fatigue in RA using bookmarking.
    Bingham CO; Butanis AL; Orbai AM; Jones M; Ruffing V; Lyddiatt A; Schrandt MS; Bykerk VP; Cook KF; Bartlett SJ
    Rheumatology (Oxford); 2021 Sep; 60(9):4306-4314. PubMed ID: 33471127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.